MedPath

Levocarnitine

Levocarnitine Oral Solution USP 1g/10mL (118mL multidose)

Approved
Approval ID

ada35959-e317-4161-ae79-3475096c679f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2021

Manufacturers
FDA

Rising Pharmaceuticals, Inc.

DUNS: 041241766

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levocarnitine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64980-503
Application NumberANDA076851
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levocarnitine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 21, 2021
FDA Product Classification

INGREDIENTS (6)

SUCROSEInactive
Code: C151H8M554
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
MALIC ACIDInactive
Code: 817L1N4CKP
Classification: IACT
LEVOCARNITINEActive
Quantity: 1 g in 10 mL
Code: 0G389FZZ9M
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.